No Detail Found!

Assessing the role of disodium pamidronate in the management of rheumatoid arthritis.

Author(s)
Anjum Ilahi Al-Nafees Medical College & Hospital, Isra University, Islamabad Campus, Islamabad, Pakistan
E. Mansur Medical Testing and Research Organization, Islamabad, Pakistan
Sahar Jameel Newfoundland and Labrador. St. Clares Mercy Hospital St. Johns Newfoundland A1c 5b8 Canada
Asma Janjua Cantonment General Hospital, Rawalpindi, Pakistan
Hasan Orooj Health Directorate, CDA, Islamabad, Pakistan
Abstract
OBJECTIVE: To assess the role of Disodium pamidronate(3-amino-1-hydroxypropylidine-1,1- bisphosphonate) in the management of Rheumatoid Arthritis. STUDY DESIGN: A prospective, open, randomized, observational, dose response comparasion (30 mg vs 15 mg of Disodium Pamidronate) study done in the medical department of Cantonment General Hospital Rawalpindi over a three month period. PATIENTS AND METHODS: 16 patients of both genders with rheumatoid arthritis were divided into two groups of 8 each. (Designated A and B.).All patients had established Rhuematoid Arthritis according to 1987 American Rheumatology association revised criteria for the diagnosis of Rheumatoid Arthritis. Each group was randomly allocated to receive a single infusion of Disodium Pamidronate of either 15 (group A) or 30 mg (group B). A number of parameters of disease activity were recorded {Grip strength (dominant hand; mean of three readings),Ritchie articular index, and early morning stiffness among others}. All patients were admitted and directly observed initially. RESULTS: Group A: Was given 15 mg Pamidronate infusion.Two (2) patients (25 %) showed improvement in clinical parameters and biochemical parameters. 6 patients showed biochemical improvement alone. Group B: Was given 30mg Pamidronate infusion. Five (5) patients (70%) showed rapid clinical and biochemical improvement which was relatively sustained for 1-3 months. All the 8 patients showed biochemical improvement. A transient flu like illness observed in one patient only however he was a responder. CONCLUSIONS: 30mg of single Disodium Pamidronate infusion in an efficacious and rapidly acting management strategy in the therapy of active rheumatoid arthritis. The response is dose related.
Publication Details
Page(s) 76-80
DOI DOI not available
Published Journal: Isra Medical Journal, Volume: 4, Issue: 2, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

83

Views